Is VYGR stock safe? | Glauxie AI

Q: Is VYGR stock safe?

Voyager Therapeutics, Inc. (VYGR) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Alfred W. Sandrock Jr.. Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is... Employees: 141.

Q: What are the risks of investing in VYGR?

Identify key risks of investing in VYGR — debt, competition, volatility, and sector headwinds.

Q: Is VYGR a good long-term investment?

Evaluate VYGR as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does VYGR have?

Review VYGR total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is VYGR stock safe?

🦉

Voyager Therapeutics, Inc. (VYGR)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOAlfred W. Sandrock Jr.

Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical...

Key Executives

Name	Title
Alfred W. Sandrock Jr.	President, Chief Executive Officer & Director
Amy Quinlan	Principal Accounting Officer
Gregory Shiferman	Senior VP, General Counsel & Secretary
Krystof Bankiewicz	Founder
Mark A. Kay	Founder
Mathieu Nonnenmacher	Vice President of Gene Therapy

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

VYGR Profile Financials

What are the risks of investing in VYGR? Is VYGR a good long-term investment? How much debt does VYGR have?